+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report by Polymer Origin (Natural, Synthetic, Hybrid), by Route (Subcutaneous, Ocular, Oral Cavity), by Region, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 130 Pages
  • July 2021
  • Region: Global
  • Grand View Research
  • ID: 5390568
The global hydrogel-based drug delivery system market size is anticipated to reach USD 10.6 billion by 2028. The market is expected to expand at a CAGR of 7.5% from 2021 to 2028. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

  • Based on polymer origin, the synthetic segment held the largest proportion of market share in 2020
  • The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology
  • The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength
  • Based on delivery route, the ocular segment accounted for the largest revenue share in 2020
  • The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out
  • North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems
  • In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Hydrogel-based Drug Delivery System Market

What is the estimated value of the Hydrogel-based Drug Delivery System Market?

The Hydrogel-based Drug Delivery System Market was estimated to be valued at $6.4 billion in 2021.

What is the growth rate of the Hydrogel-based Drug Delivery System Market?

The growth rate of the Hydrogel-based Drug Delivery System Market is 7.5%, with an estimated value of $10.6 billion by 2028.

What is the forecasted size of the Hydrogel-based Drug Delivery System Market?

The Hydrogel-based Drug Delivery System Market is estimated to be worth $10.6 billion by 2028.

Who are the key companies in the Hydrogel-based Drug Delivery System Market?

Key companies in the Hydrogel-based Drug Delivery System Market include Ferring B.V., Endo International plc, Akorn, Incorporated, Tolmar Pharmaceuticals, Inc, GALDERMA, Blairex Laboratories, Inc., Johnson & Johnson, Bausch and Lomb, Medtronic and Ocular Therapeutix, Inc..

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Polymer origin
1.1.2. Delivery route
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Regional outlook
2.3. Competitive Insights
Chapter 3. Hydrogel Based Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.4.3. Market opportunity analysis
3.4.4. Market challenge analysis
3.5. Hydrogel Based Drug Delivery Systems Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals &strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Global Hydrogel Based Drug Delivery Systems Market: Polymer Origin Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Natural
4.1.2. Synthetic
4.1.3. Hybrid
4.2. Global Hydrogel Based Drug Delivery Systems Market Share, 2020&2028
4.3. Segment Dashboard
4.4. Global Hydrogel Based Drug Delivery Systems Market by Polymer Origin Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2020 to 2028 for the following
4.5.1. Natural
4.5.1.1. Natural market, 2016 - 2028 (Revenue, USD Million)
4.5.2. Synthetic
4.5.2.1. Synthetic Market, 2016 - 2028 (Revenue, USD Million)
4.5.3. Hybrid
4.5.3.1. Hybrid Market, 2016 - 2028 (Revenue, USD Million)
Chapter 5. Global Hydrogel Based Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Subcutaneous
5.1.2. Ocular
5.1.3. Oral Cavity
5.1.4. Topical
5.1.5. Other
5.2. Global Hydrogel Based Drug Delivery Systems Market Share, 2020&2028
5.3. Segment Dashboard
5.4. Global Hydrogel Based Drug Delivery Systems Market by Delivery Route Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2020 to 2028 for the following
5.5.1. Subcutaneous
5.5.1.1. Subcutaneous market, 2016 - 2028 (Revenue, USD Million,)
5.5.2. Ocular
5.5.2.1. Ocular Market, 2016 - 2028 (Revenue, USD Million)
5.5.3. Oral Cavity
5.5.3.1. Oral Cavity Market, 2016 - 2028 (Revenue, USD Million)
5.5.4. Topical
5.5.4.1. Topical Market, 2016 - 2028 (Revenue, USD Million)
5.5.5. Other
5.5.5.1. Other Market, 2016 - 2028 (Revenue, USD Million)
Chapter 6. Global Hydrogel Based Drug Delivery Systems Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2020&2028
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2021
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2028:
6.7. North America
6.7.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.7.2. U.S.
6.7.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.7.3. Canada
6.7.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.2. U.K.
6.8.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.3. Germany
6.8.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.4. France
6.8.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.5. Italy
6.8.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.6. Spain
6.8.6.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.2. Japan
6.9.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.3. China
6.9.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.4. India
6.9.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.5. South Korea
6.9.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.6. Thailand
6.9.6.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.2. Brazil
6.10.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.3. Mexico
6.10.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.4. Argentina
6.10.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Market estimates and forecast, 2016 - 2028(Revenue, USD
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.2.2. Market leaders
7.2.3. Emerging players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2020
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company market share/ranking, by region
7.4.3. Competitive dashboard analysis
7.4.3.1. Market differentiators
7.4.3.2. Synergy analysis: major deals and strategic alliances
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Funding outlook
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.5. Supplier ranking
7.5.6. Key company profiled
7.5.7. Ferring B.V.
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Endo International plc
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Akorn, Incorporated
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Tolmar Pharmaceuticals, Inc
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. GALDERMA
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Blairex Laboratories, Inc.
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Johnson & Johnson
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Bausch and Lomb
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
7.5.15. Medtronic
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Product benchmarking
7.5.15.4. Strategic initiatives
7.5.16. Ocular Therapeutix, Inc.
7.5.16.1. Company overview
7.5.16.2. Financial performance
7.5.16.3. Product benchmarking
7.5.16.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America hydrogel-based drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 3 North America hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 4 North America hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 5 U.S. hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 6 U.S. hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 7 Canada hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 8 Canada hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 9 Europe hydrogel-based drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 10 Europe hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 11 Europe hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 12 U.K. hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 13 U.K. hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 14 Germany hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 15 Germany hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 16 France hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 17 France hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 18 Italy hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 19 Italy hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 20 Spain hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 21 Spain hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 22 Asia Pacific hydrogel-based drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 23 Asia Pacific hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 24 Asia Pacific hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 25 Japan hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 26 Japan hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 27 India hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 28 India hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 29 China hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 30 China hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 31 South Korea hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 32 South Korea hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 33 Thailand hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 34 Thailand hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 35 Latin America hydrogel-based drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 36 Latin America hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 37 Latin America hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 38 Brazil hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 39 Brazil hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 40 Mexico hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 41 Mexico hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 42 Argentina hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 43 Argentina hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 44 MEA hydrogel-based drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 45 MEA hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 46 MEA hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 47 South Africa hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 48 South Africa hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 49 Saudi Arabia hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 50 Saudi Arabia hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
Table 51 UAE hydrogel-based drug delivery systems market, by polymer origin, 2016 - 2028 (USD Million)
Table 52 UAE hydrogel-based drug delivery systems market, by delivery route, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Hydrogel based drug delivery systems market: market outlook
Fig. 14 Hydrogel based drug delivery systems market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Hydrogel based drug delivery systems market driver impact
Fig. 20 Hydrogel based drug delivery systems market restraint impact
Fig. 21 Hydrogel based drug delivery systems market strategic initiatives analysis
Fig. 22 Hydrogel based drug delivery systems market: polymer origin movement analysis
Fig. 23 Hydrogel based drug delivery systems market: polymer origin outlook and key takeaways
Fig. 24 Natural market estimates and forecast, 2016 - 2028
Fig. 25 Synthetic market estimates and forecast, 2016 - 2028
Fig. 26 Hybrid market estimates and forecast, 2016 - 2028
Fig. 27 Hydrogel based drug delivery systems market: delivery route movement analysis
Fig. 28 Hydrogel based drug delivery systems market: delivery route outlook and key takeaways
Fig. 29 Subcutaneous market estimates and forecast, 2016 - 2028
Fig. 30 Ocular market estimates and forecast, 2016 - 2028
Fig. 31 Oral cavity market estimates and forecast, 2016 - 2028
Fig. 32 Topical market estimates and forecast, 2016 - 2028
Fig. 33 Other market estimates and forecast, 2016 - 2028
Fig. 34 Global Hydrogel based drug delivery systems market: regional movement analysis
Fig. 35 Global Hydrogel based drug delivery systems market: regional outlook and key takeaways
Fig. 36 Global Hydrogel based drug delivery systems market share and leading players
Fig. 37 North America market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Asia Pacific market share and leading players
Fig. 40 Latin America market share and leading players
Fig. 41 Middle East & Africa market share and leading players
Fig. 42 North America: SWOT
Fig. 43 Europe SWOT
Fig. 44 Asia Pacific SWOT
Fig. 45 Latin America SWOT
Fig. 46 MEA SWOT
Fig. 47 North America, by country
Fig. 48 North America
Fig. 49 North America market estimates and forecast, 2016 - 2028
Fig. 50 U.S.
Fig. 51 U.S. market estimates and forecast, 2016 - 2028
Fig. 52 Canada
Fig. 53 Canada market estimates and forecast, 2016 - 2028
Fig. 54 Europe
Fig. 55 Europe market estimates and forecast, 2016 - 2028
Fig. 56 U.K.
Fig. 57 U.K. market estimates and forecast, 2016 - 2028
Fig. 58 Germany
Fig. 59 Germany market estimates and forecast, 2016 - 2028
Fig. 60 France
Fig. 61 France market estimates and forecast, 2016 - 2028
Fig. 62 Italy
Fig. 63 Italy market estimates and forecast, 2016 - 2028
Fig. 64 Spain
Fig. 65 Spain market estimates and forecast, 2016 - 2028
Fig. 66 Asia Pacific
Fig. 67 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 68 China
Fig. 69 China market estimates and forecast, 2016 - 2028
Fig. 70 Japan
Fig. 71 Japan market estimates and forecast, 2016 - 2028
Fig. 72 India
Fig. 73 India market estimates and forecast, 2016 - 2028
Fig. 74 Thailand
Fig. 75 Thailand market estimates and forecast, 2016 - 2028
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecast, 2016 - 2028
Fig. 78 Latin America
Fig. 79 Latin America market estimates and forecast, 2016 - 2028
Fig. 80 Brazil
Fig. 81 Brazil market estimates and forecast, 2016 - 2028
Fig. 82 Mexico
Fig. 83 Mexico market estimates and forecast, 2016 - 2028
Fig. 84 Argentina
Fig. 85 Argentina market estimates and forecast, 2016 - 2028
Fig. 86 Middle East and Africa
Fig. 87 Middle East and Africa. market estimates and forecast, 2016 - 2028
Fig. 88 South Africa
Fig. 89 South Africa market estimates and forecast, 2016 - 2028
Fig. 90 Saudi Arabia
Fig. 91 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 92 UAE
Fig. 93 UAE market estimates and forecast, 2016 - 2028
Fig. 94 Participant categorization- Hydrogel based drug delivery systems market
Fig. 95 Market share of key market players- Hydrogel based drug delivery systems market

Companies Mentioned

  • Ferring B.V.
  • Endo International plc
  • Akorn, Incorporated
  • Tolmar Pharmaceuticals, Inc
  • GALDERMA
  • Blairex Laboratories, Inc.
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix, Inc.

Methodology

Loading
LOADING...